Skip to main content
Home » Reports » Healthcare » Blood Ketone Meter Market
ReesrachMoz Brochure Icon

Global Blood Ketone Meter Market Analysis and Forecast 2020-2028

Report ID:633Healthcare256 pages

Blood Ketone Meter Market Statistics

The global blood ketone meter market was valued at USD 0.27 bn in 2020, however growing at a CAGR of 6.8% from 2020 to 2028, it is estimated to reach USD 0.50bn.

The rising incidence of diabetes-related complications and increasing prevalence of obesity are the major factors that are projected to drive the growth of this market during the forecast period.

Prevalence of Lifestyle Diseases to Drive the Blood Ketone Meter Market

The increasing prevalence of lifestyle diseases such as obesity and the surge in diabetes related complications are projected to drive the growth in the market. Post covid pandemic the number of lifestyle diseases has only witnessed a surge, owing to a boost in the sales of blood ketone meters. Rising investment in research and development for the betterment of novel blood ketone metres is estimated to fuel the demand for the blood ketone metres market during the forecast period.

Global Blood Ketone Meter Market Share By Region Type

Diabetes to Boost the Sales of Blood Ketone Meters

Growing cases of diabetic population is one of the major factors augmenting the growth in the blood ketone metres market. According to WHO (World Health Organization), 2.5 billion people worldwide have diabetes mellitus, meaning that about 40% of adults in the world are either diabetic or prediabetic. Adding to the momentum, the demand for the blood ketone metre market is likely to grow up over the next few years. The device is used by individuals suffering from diabetes to monitor their blood glucose levels and to prevent ketoacidosis, resulting in boosting the demand for ketone meters.

The demand for blood ketone meters is increasing globally as beta-hydroxybutyrate testing is becoming a part of routine diabetes management. Blood ketone testing allows diabetics to better visualize the effectiveness of their diet and reduce the risk of negative side effects associated with uncontrolled diabetes. These factors are likely to strengthen the global blood ketone metres market in the coming years.

The product recall will hamper the growth of the blood ketone meter market in the near future. For instance, in November 2019, the U.S. Food and Drug Administration announced the product recall of Precision Xtra Blood Glucose & Ketone Monitoring System manufactured by Abbott Laboratories. Also, high cost involved in the diagnostics test will hamper market growth during forecast period.

Nevertheless, the new product launches of new blood ketone meters that facilitate monitoring of diabetic ketoacidosis will boost market growth.

Diabetic Complications to Drive the Glucose and Ketone Segment.

Based on product type, the blood glucose and ketone monitoring segment are expected to register significant growth during the forecast period.  The growth can be attributed to the increasing number of diabetic patients globally, who are at a high risk of ketoacidosis resulting from the over detection of blood glucose levels. They are also widely adopted by dairy farmers and vets to monitor ketones in cattle, thus driving this segment of the product.

On the basis of applications, Blood ketone meters have been increasingly employed by humans with different types of diabetes that are insulin-dependent in order to monitor their blood glucose levels and help them achieve better health outcomes. They may also be useful for athletes that adhere to a ketogenic diet and want to verify if they are in the state of ketosis. This rise in usage is further expected to foster the growth of this segment over the forecast period.

Based on end-users, the global blood ketone meter market is segmented into- hospitals, homecare settings, diagnostic centres, and others. However, the home healthcare segment is projected to generate revenue during the forecast period. Home healthcare services are also preferred by people to avoid the stress and anxiety associated with long-term hospital admissions. The availability of trained nurses and their access to even home settings are expected to fuel the growth of this segment over the forecast years.

Regional Overview

In terms of regional growth, North America is expected to continue its dominance in the global blood ketone metres market. The increasing occurrence of diabetes is anticipated to create demand for blood ketone meters for measuring ketone levels. Government initiatives to promote glucose and ketone monitoring are estimated to substantially augment the market growth.

Europe is anticipated to register higher growth during the forecast period. Increasing public awareness regarding diabetes diagnoses, collaborations between key players, and government initiatives toward promoting glucose monitoring are projected to propel the demand for blood ketone meters during the forecast period.

The Asia Pacific is also likely to witness a surge in the demand due to the rising patient pool and an increase in lifestyle diseases.

Competitive Landscape

In 2021, NIPRO Corporation announced its joint establishment of a production plant for cellulose triacetate (CTA) dialyzers (artificial kidneys) in partnership with Toyobo Co., Ltd. The device will help purify the blood and remove body wastes and other toxins by dialysis for patients suffering from chronic renal failure.

In 2020, Nova Biomedical StatStrip Glucose Hospital Meter System received approval from Health Canada to use in all hospitals and healthcare facilities. StatStrip Glucose and StatStrip Glucose/Ketone meters the only monitoring system designed to detect and manage dysglycemia in all healthcare settings including in intensive care units.

In 2022, GlucoRx Limited teamed up with NHS to provide continuous glucose for free to patients in the UK living with diabetes 1.

Following are the major players in the global blood ketone market

  • Abbott Laboratories
  • APEX Biotechnology Corporation
  • Nova Biomedical
  • KETO-MOJO
  • APEX Biotechnology Corporation
  • TaiDoc Technology Corporation
  • GlucoRx Limited
  • PortaCheck Inc.

Product Type Outlook (Revenue, USD Billion)

  • Blood Glucose and Ketone Monitoring
  • Blood Ketone Monitoring
  • Consumables

Application Outlook (Revenue, USD Billion)

  • Human
  • Veterinary

End-use Outlook (Revenue, USD Billion)

  • Hospitals
  • Homecare Settings
  • Diagnostic Centers
  • Others

Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

  • What will be the growth rate of the global blood ketone metres market?
  • The global blood ketone market is expected to witness a CAGR of 6.8% from 2020 to 2028
  • What would be the estimated size of the blood ketone metres market?
  • The global blood ketone metres market is projected to reach an estimated value of
  • What are the factors that drive the global blood ketone metres market?
  • Increasing prevalence of diabetes and associated lifestyle diseases are expected to drive the blood ketone metres market
  • Which region is likely to dominate the blood ketone metres market during the forecast period?
  • North America is likely to dominate the blood ketone market, owing to increasing awareness and government support.

Table Of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Blood Ketone Meter Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type Outlook
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type Outlook, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type Outlook, 2022-2032
5.3.1. Blood Glucose and Ketone Monitoring
5.3.2. Blood Ketone Monitoring
5.3.3. Consumables
5.4. Y-o-Y Growth Trend Analysis By Product Type Outlook, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type Outlook, 2022-2032

6. Global Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Application Outlook
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Outlook, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Outlook, 2022-2032
6.3.1. Human
6.3.2. Veterinary
6.4. Y-o-Y Growth Trend Analysis By Application Outlook, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application Outlook, 2022-2032

7. Global Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By End-use Outlook
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End-use Outlook, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End-use Outlook, 2022-2032
7.3.1. Hospitals
7.3.2. Homecare Settings
7.3.3. Diagnostic Centers
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End-use Outlook, 2017-2021
7.5. Absolute $ Opportunity Analysis By End-use Outlook, 2022-2032

8. Global Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region

9. North America Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type Outlook
9.2.3. By Application Outlook
9.2.4. By End-use Outlook
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type Outlook
9.3.3. By Application Outlook
9.3.4. By End-use Outlook
9.4. Key Takeaways

10. Latin America Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Product Type Outlook
10.2.3. By Application Outlook
10.2.4. By End-use Outlook
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type Outlook
10.3.3. By Application Outlook
10.3.4. By End-use Outlook
10.4. Key Takeaways

11. Europe Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Type Outlook
11.2.3. By Application Outlook
11.2.4. By End-use Outlook
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type Outlook
11.3.3. By Application Outlook
11.3.4. By End-use Outlook
11.4. Key Takeaways

12. East Asia Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type Outlook
12.2.3. By Application Outlook
12.2.4. By End-use Outlook
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type Outlook
12.3.3. By Application Outlook
12.3.4. By End-use Outlook
12.4. Key Takeaways

13. South Asia Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type Outlook
13.2.3. By Application Outlook
13.2.4. By End-use Outlook
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type Outlook
13.3.3. By Application Outlook
13.3.4. By End-use Outlook
13.4. Key Takeaways

14. Oceania Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type Outlook
14.2.3. By Application Outlook
14.2.4. By End-use Outlook
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type Outlook
14.3.3. By Application Outlook
14.3.4. By End-use Outlook
14.4. Key Takeaways

15. MEA Blood Ketone Meter Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Product Type Outlook
15.2.3. By Application Outlook
15.2.4. By End-use Outlook
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type Outlook
15.3.3. By Application Outlook
15.3.4. By End-use Outlook
15.4. Key Takeaways

16. Key Countries Blood Ketone Meter Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Type Outlook
16.1.2.2. By Application Outlook
16.1.2.3. By End-use Outlook
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Type Outlook
16.2.2.2. By Application Outlook
16.2.2.3. By End-use Outlook
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Type Outlook
16.3.2.2. By Application Outlook
16.3.2.3. By End-use Outlook
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Type Outlook
16.4.2.2. By Application Outlook
16.4.2.3. By End-use Outlook
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Type Outlook
16.5.2.2. By Application Outlook
16.5.2.3. By End-use Outlook

17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1.  By Regional
17.3.2.  By Product Type Outlook
17.3.3.  By Application Outlook
17.3.4.  By End-use Outlook

18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Abbott Laboratories
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. APEX Biotechnology Corporation
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Nova Biomedical
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. KETO-MOJO
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. APEX Biotechnology Corporation
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. TaiDoc Technology Corporation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. GlucoRx Limited
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. PortaCheck Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Request Free Sample

Hidden
Company logos Strips